The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

qpNCA: Noncompartmental Pharmacokinetic Analysis by qPharmetra

Computes noncompartmental pharmacokinetic parameters for drug concentration profiles. For each profile, data imputations and adjustments are made as necessary and basic parameters are estimated. Supports single dose, multi-dose, and multi-subject data. Supports steady-state calculations and various routes of drug administration. See ?qpNCA and vignettes. Methodology follows Rowland and Tozer (2011, ISBN:978-0-683-07404-8), Gabrielsson and Weiner (1997, ISBN:978-91-9765-100-4), and Gibaldi and Perrier (1982, ISBN:978-0824710422).

Version: 1.1.6
Depends: R (≥ 3.3.0)
Imports: dplyr (≥ 0.7.0), tidyr (≥ 0.8.2), magrittr, ggplot2, knitr
Suggests: rmarkdown, markdown, covr, testthat (≥ 2.1.0)
Published: 2021-08-16
DOI: 10.32614/CRAN.package.qpNCA
Author: Jan Huisman [aut, cre], Koen Jolling [ctb], Krina Mehta [ctb], Tim Bergsma [ctb]
Maintainer: Jan Huisman <jan.huisman at qpharmetra.com>
License: GPL-3
NeedsCompilation: no
Materials: README
In views: MissingData, Pharmacokinetics
CRAN checks: qpNCA results

Documentation:

Reference manual: qpNCA.pdf
Vignettes: Parameter Guidelines
A User Guide for qpNCA
Example Full NCA Analysis
Example Stepwise NCA Analysis

Downloads:

Package source: qpNCA_1.1.6.tar.gz
Windows binaries: r-devel: qpNCA_1.1.6.zip, r-release: qpNCA_1.1.6.zip, r-oldrel: qpNCA_1.1.6.zip
macOS binaries: r-release (arm64): qpNCA_1.1.6.tgz, r-oldrel (arm64): qpNCA_1.1.6.tgz, r-release (x86_64): qpNCA_1.1.6.tgz, r-oldrel (x86_64): qpNCA_1.1.6.tgz
Old sources: qpNCA archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=qpNCA to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.